Shares of the company are trading at $7.19 marginally over $6.74, the 50 day moving average and quite a bit higher than the 200 day moving average of $5.80. The 50 day moving average was up $0.45 and the 200 day average was up $1.40. 0 shares changed hands on Wednesday. Trading volume was down nan% under the stocks average daily volume.
GenVec, Inc. (GenVec), launched on December 7, 1992, is a clinical-stage biopharmaceutical company, engaged in the development of therapeutics and vaccines. The Company designs, tests and manufactures adenoviral-based product candidates. The Business’s development programs address therapeutic areas, such as hearing loss and balance disorders, as well as vaccines against infectious diseases, including respiratory syncytial virus (RSV), herpes simplex virus (HSV), Enterovirus D68 (EV-D68) and malaria. In the area of animal health, it is developing vaccines against foot-and-mouth disease (FMD). The Company develops and commercializes its product candidates through collaborations..